OptimizeRx (OPRX) Other financing activities (2010 - 2025)

OptimizeRx (OPRX) has 8 years of Other financing activities data on file, last reported at $14000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other financing activities changed N/A year-over-year to $14000.0; the trailing twelve-month figure through Dec 2025 stood at $120000.0 (down 17.81% YoY), and the FY2025 full-year result was $352000.0, changed N/A from the prior year.
• Other financing activities grew to $14000.0 in Q4 2025, from $1000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.6 million in Q2 2021 to a low of $1000.0 in Q3 2023.
• A 4-year average of $508142.7 and a median of $238879.0 in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities surged 898.65% in 2021 and slumped 99.54% in 2023, its largest moves.
• Tracing OPRX's Other financing activities over 4 years: stood at $1.1 million in 2021, then sank by 97.79% to $23377.0 in 2022, then tumbled by 95.72% to $1000.0 in 2023, then surged by 1300.0% to $14000.0 in 2025.
• Business Quant data shows OPRX's Other financing activities at $14000.0 in Q4 2025, $1000.0 in Q3 2023, and $105000.0 in Q2 2023.